Rodman & Renshaw Reiterate Buy On Synergy Pharma Following Plecanatide Phase 3 Report
May 23, 2016 at 09:33 AM EDT
Rodman & Renshaw's Raghuram Selvaraju reiterated his Buy position on Synergy Pharmaceuticals Inc (NASDAQ: SGYP) with a price target of ...